TrialJCI insight2024

An intranasally administered adenovirus-vectored SARS-CoV-2 vaccine induces robust mucosal secretory IgA.

Baoqing Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.